MRI-Guided thrombolysis for stroke with unknown time of onset

New England Journal of Medicine

Volumn 379, Issue 7, 2018, Pages 611-622

  Thomalla, G ^a   Simonsen, C Z ^l   Boutitie, F ^o,q   Andersen, G ^l   Berthezene, Y ^p   Cheng, B ^a   Cheripelli, B ^r   Cho, T H ^q   Fazekas, F ^c   Fiehler, J ^a   Ford, I ^s   Galinovic, I ^d   Gellissen, S ^a   Golsari, A ^a   Gregori, J ^g   Gunther M ^g,j   Guibernau, J ^t   Hausler K G ^d,e   Hennerici, M ^h   Kemmling, A ^k   Marstrand, J ^m   Modrau, B ⁿ   Neeb, L ^e   Perez De La Ossa, N ^u   Puig, J ^v   Ringleb, P ⁱ   Roy, P ^o,q   Scheel, E ^b   Schonewille, W ^x   Serena, J ^w   Sunaert, S ^y   Villringer, K ^d   Wouters, A ^z,aa,ab   Thijs, V ^ac   Ebinger, M ^d,f   Endres, M ^d,e   Fiebach, J B ^d   Lemmens, R ^z,aa,ab   Muir, K W ^r   Nighoghossian, N ^q   Pedraza, S ^v   Gerloff, C ^a   more..

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b ZytoService Deutschland   (Germany)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d Centrum für Schlaganfallforschung Berlin   (Germany)

^e Klinik und Hochschulambulanz für Neurologie   (Germany)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g Mediri   (Germany)

^h UNIVERSITY OF HEIDELBERG   (Germany)

ⁱ UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^j UNIVERSITY OF BREMEN   (Germany)

^k UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^l AARHUS UNIVERSITY HOSPITAL   (Denmark)

^m BISPEBJERG HOSPITAL   (Denmark)

ⁿ AALBORG UNIVERSITY HOSPITAL   (Denmark)

^o HOSPICES CIVILS DE LYON   (France)

^p UNIVERSITÉ DE LYON   (France)

^q UNIVERSITÉ LYON 1   (France)

^r UNIVERSITY OF GLASGOW   (United Kingdom)

^s UNIVERSITY OF GLASGOW   (United Kingdom)

^t Salut Emporda Foundation   (Spain)

^u HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^v GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^w HOSPITAL JOSEP TRUETA   (Spain)

^x UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^y DEPARTMENT OF IMAGING AND PATHOLOGY   (Belgium)

^z UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^aa KU LEUVEN UNIVERSITY OF LEUVEN   (Belgium)

^ab UNIVERSITY OF LEUVEN   (Belgium)

^ac FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DIFFUSION WEIGHTED IMAGING; DRUG FATALITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; RANKIN SCALE; THROMBECTOMY; TREATMENT OUTCOME; ACUTE DISEASE; CHEMICALLY INDUCED; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FIBRINOLYTIC THERAPY; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; TIME TO TREATMENT;

ACUTE DISEASE; ADMINISTRATION, INTRAVENOUS; AGED; BRAIN ISCHEMIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INTRACRANIAL HEMORRHAGES; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MALE; MIDDLE AGED; STROKE; THROMBECTOMY; THROMBOLYTIC THERAPY; TIME-TO-TREATMENT; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 85050200415     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1804355     Document Type: Article

References (24)

1. Lees KR, Emberson J, Blackwell L, et al. Effects of alteplase for acute stroke on the distribution of functional outcomes: a pooled analysis of 9 trials. Stroke 2016; 47:2373-9.
2. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29.
3. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581-7.
4. Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2018;49(3):e46-e110.
5. Fink JN, Kumar S, Horkan C, et al. The stroke patient who woke up: clinical and radiological features, including diffusion and perfusion MRI. Stroke 2002; 33:988-93.
6. Mackey J, Kleindorfer D, Sucharew H, et al. Population-based study of wake-up strokes. Neurology 2011;76:1662-7.
7. Rimmele DL, Thomalla G. Wake-up stroke: clinical characteristics, imaging findings, and treatment option — an update. Front Neurol 2014;5:35.
8. Thomalla G, Rossbach P, Rosenkranz M, et al. Negative fluid-attenuated inversion recovery imaging identifies acute ischemic stroke at 3 hours or less. Ann Neurol 2009;65:724-32.
9. Aoki J, Kimura K, Iguchi Y, Shibazaki K, Sakai K, Iwanaga T. FLAIR can estimate the onset time in acute ischemic stroke patients. J Neurol Sci 2010;293:39-44.
10. Petkova M, Rodrigo S, Lamy C, et al. MR imaging helps predict time from symptom onset in patients with acute stroke: implications for patients with unknown onset time. Radiology 2010;257: 782-92.
11. Thomalla G, Cheng B, Ebinger M, et al. DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study. Lancet Neurol 2011;10:978-86.
12. Thomalla G, Fiebach JB, Østergaard L, et al. A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP). Int J Stroke 2014;9: 829-36.
13. Thomalla G, Boutitie F, Fiebach JB, et al. Stroke with unknown time of symptom onset: baseline clinical and magnetic resonance imaging data of the first thousand patients in WAKE-UP (Efficacy and Safety of MRI-Based Thrombolysis in Wake-up Stroke: A Randomized, Doubleblind, Placebo-Controlled Trial). Stroke 2017;48: 770-3.
14. European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008;25:457-507.
15. von Kummer R, Broderick JP, Campbell BC, et al. The Heidelberg Bleeding Classification: classification of bleeding events after ischemic stroke and reperfusion therapy. Stroke 2015;46:2981-6.
16. Wahlgren N, Ahmed N, Dávalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementa-
17. tion of Thrombolysis in Stroke Monitoring Study (SITS-MOST): an observational study. Lancet 2007;369:275-82.
18. Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998;352:1245-51.
19. Little RJA, Rubin DB. Statistical analysis with missing data. New York: John Wiley & Sons, 2002.
20. Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 375:1695-703.
21. Galinovic I, Puig J, Neeb L, et al. Visual and region of interest-based inter-rater agreement in the assessment of the diffusion-weighted imaging-fluid-attenuated inversion recovery mismatch. Stroke 2014; 45:1170-2.
22. Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 2018;378:11-21.
23. Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 2018;378:708-18.
24. Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014;384:1929-35.